Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
25 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
367
146 (4%)
70 (29%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2018-12-12 | 2019-01-03 | 69447 |
| APO-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2024-05-31 | 2024-07-05 | 229395 |
| APO-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2024-06-06 | 2024-09-27 | 229758 |
| APO-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2024-11-07 | 2024-11-29 | 242199 |
| APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2022-11-18 | 2022-12-05 | 175299 |
| APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2022-11-20 | 2022-12-02 | 175309 |
| APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2017-06-13 | 2017-07-17 | 12668 |
| APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2025-03-13 | 2025-04-04 | 252554 |
| APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2018-05-22 | 2018-09-08 | 49967 |
| APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2018-08-09 | 2018-10-13 | 57772 |
| APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2024-03-08 | 2024-04-19 | 221726 |
| APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2017-09-26 | 2017-11-07 | 23536 |
| APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2017-12-19 | 2018-07-03 | 33783 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2017-12-19 | 2018-07-04 | 33780 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2017-06-26 | 2017-07-17 | 13970 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2017-07-26 | 2017-11-07 | 17202 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2017-07-26 | 2017-10-24 | 17205 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2023-05-26 | 2023-07-13 | 193203 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2019-09-25 | 2019-10-22 | 94731 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2018-05-22 | 2018-09-09 | 49970 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |